
Urine proteome provides potential biomarkers for early prediction of COVID-19 progression
Published 31 August, 2021
Improving early detection of COVID-19, along with predictions around which patients are likely to develop severe symptoms, is a high priority. In this study published in Urine, researchers from the China and the US used urine proteomic profiling to distinguish a healthy control group from COVID-19 patients. In addition, they were able to identify specific proteome features in the urine of patients that indicated whether they had mild or severe COVID-19.